Selected Publications

Tumor Stroma and Drug Pharmacology:

  • Peister A, Mellad JA, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103(5):1662-68, 2004.
  • Studebaker AW, Werbeck JL, Sasser AK, Huang T, Chan MW, Marini FC, Rosol TJ, Hall BM. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates in an interleukin-6-dependent manner. Cancer Res. 68(21):9087-95, 2008.
  • Spaeth E, Dembinski J, Sasser AK, Watson K, Klopp A., Hall BM, Andreeff M, Marini FC. Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts in Carcinomas contributes to Fibrovascular Network Expansion, and Tumor Progression. PLoS One 4(4):e4992, 2009.
  • David Onion, Richard Argent, Alexander Reece-Smith, Madeleine Craze, Robert, Pineda, Hari Ratan, Simon Parsons, John Duffy, John Atherton, Andrew McKenzie, Rajendra Kumari, Peter King, Brett Hall, Sue Watson, Anna Grabowska. 3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal cells but Sensitivity to Histone Deacetylase Inhibitors. Mol. Cancer Ther. In press, 2016 (PMID: 26873730).

Tumor Microenvironment & 3D Modeling:

  • Sasser AK, Mundy BL, Smith KM, Studebaker AW, Axel AE, Haidet AM, Fernandez SA, Hall BM. Human Bone Marrow Stromal Cells Enhance Breast Cancer Cell Growth Rates in a Cell Line Dependent Manner when Evaluated in 3D Tumor Microenvironments. Cancer Letters, 254(2):255-264, 2007.
  • Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Hall BM. Interleukin-6 is a potent growth factor for ER-a positive human breast cancer. FASEB J., 21(13):3763-3770, 2007.
  • Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28(33):2940-7, 2009.
  • Krausz E, de Hoogt R, Gustin E, Cornelissen F, Grand-Perret T, Janssen L, Vloemans N, Wuyts D, Frans S, Axel A, Peeters PJ, Hall BM, Cik M. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening. J Biomol Screen 18(1):54-66, 2013.
  • Casneuf T, Axel AE, King PJ, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK. Interleukin-6 is a Potential Therapeutic Target in Interleukin-6-Dependent, Estrogen Receptor-alpha-Positive Breast Cancer. Breast Cancer: Targets and Therapy. 8:13-27, 2016.